Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure: Implications of Emerging Data

Author： Macfarlane David P. Fisher Miles

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.5, 2006-01, pp. : 297-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Treatment of Heart Failure in Patients with Diabetes Mellitus

By Lavine S.J. Gellman S.D.

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 285-307

Adis International

Access to resources Recommend Favorite

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials

By Hernandez Adrian V.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 2, 2011-04 ,pp. : 115-128

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may confer a reduced risk of lung cancer in patients with diabetes mellitus

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Heart failure warnings for thiazolidinediones

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite